Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 2Terminated 1

Sponsor Class

OTHER 340INDUSTRY 198NIH 27NETWORK 14OTHER_GOV 4UNKNOWN 1INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Recurrence 1Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Oxaliplatin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × FED × Head & Neck × Clear all
NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡